Procoagulant microparticles: 'criminal partners' in atherothrombosis and deleterious cellular exchanges

Area of Science:

• Cardiovascular Research
• Thrombosis and Hemostasis
• Atherosclerosis Pathophysiology

Background:

• Procoagulant microparticles (MP) are indicators of vascular cell damage and key players in atherothrombosis.
• Elevated MP levels are associated with cardiovascular risk factors and contribute to vascular inflammation and dysfunction.
• MPs within atherosclerotic plaques, particularly those expressing tissue factor (TF), significantly increase thrombogenicity.

Purpose of the Study:

• To elucidate the multifaceted role of circulating and plaque-bound MPs in the development and progression of atherosclerotic disease.
• To highlight the contribution of MPs to plaque vulnerability and thrombotic events.
• To re-evaluate the contribution of blood-borne versus plaque-bound TF in thrombus formation.

Main Methods:

• Review and synthesis of existing literature on microparticle biology in cardiovascular disease.
• Analysis of the mechanisms by which MPs influence vascular inflammation, endothelial dysfunction, and leukocyte recruitment.
• Examination of the role of MP-associated tissue factor in coagulation and thrombus propagation.

Main Results:

• Circulating MPs promote vascular inflammation, endothelial dysfunction, and leukocyte adhesion, contributing to plaque growth and thrombosis.
• Plaque-derived MPs, rich in tissue factor, are major determinants of plaque thrombogenicity.
• Blood-borne MPs carrying TF are likely crucial for rapid thrombus growth following plaque rupture.

Conclusions:

• Microparticles are integral to atherosclerotic disease pathogenesis, acting as critical mediators of vascular damage and thrombotic events.
• MPs contribute to plaque vulnerability through various mechanisms beyond their procoagulant activity.
• MPs are significant contributors to acute ischemic syndromes, acting as "partners in crime" in these critical conditions.